|
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... |
|
Enduring |
|
$0.00 |
|
Conversations in Neurology: New Agents and Strategies for Migraine and Related Headache Disorders Edition (Credit Expired) |
|
Enduring |
|
$0.00 |
|
On Target with “OFF” Therapies: An Exploration of New Agents and Strategies for Parkinson’s Disease (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Networks in Neurology: Insights From a Collaborative CME Experience With Practicing Clinicians Regarding New Agents and Strategies for Multiple... |
|
Enduring |
|
$0.00 |
|
Multiple Sclerosis Management: Shedding Light on the Patient Perspective (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Over-Impacted, Under-Represented: Addressing Health Disparities in Multiple Sclerosis |
|
Enduring |
|
$0.00 |
|
Different Strokes: Addressing Real Clinician Questions and Controversies Surrounding Acute Management of Ischemic Stroke (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Evolution of Progression: An Expert Forum on Advancements in Monitoring and Treating Multiple Sclerosis (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology |
|
Enduring |
|
$0.00 |
|
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy |
|
Enduring |
|
$0.00 |
|
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
|
From the Ground Up: Evolving Strategies in the Identification and Team-based Management of Patients with Early-Stage Alzheimer’s Disease Neurobiology |
|
Enduring |
|
$0.00 |
|
A Deeper Look at Neuromyelitis Optica Spectrum Disorder: A Glimpse Onto the Clinic Floor with Specialists |
|
Enduring |
|
$0.00 |
|
Battle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, and Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis |
|
Enduring |
|
$0.00 |
|
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success |
|
Enduring |
|
$0.00 |
Facebook
X
LinkedIn
Forward